One year after Wall Street banned the use of generative artificial intelligence (GenAI) bots, the prevailing defensive stance towards the technology has shifted to one of active exploration.
Even banks – known for their conservatism and risk aversion – are now racing to experiment with hundreds of use cases. Some are already opening up access to GenAI’s possibilities to large numbers of employees.
But in the midst of this boom, one question has become a persistently worrisome part of the
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
